🇺🇸 subcutaneous tocilizumab in United States

subcutaneous tocilizumab (subcutaneous tocilizumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

subcutaneous tocilizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is subcutaneous tocilizumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for subcutaneous tocilizumab in United States?

Centre Hospitalier Régional d'Orléans is the originator. The local marketing authorisation holder may differ — check the official source linked above.